This scenario is not unusual. It is, in fact, the norm for modern pharmaceutical development. And it raises an immediate practical question: whose rules apply?

The answer is both simple and complex. Simple, because a foundational principle holds across all major jurisdictions: protect research participants, ensure data reliability. Complex, because each regulatory authority has its own laws, its own procedures, its own interpretations. A clinical trial conducted in Tokyo must satisfy Japanese requirements. The same trial's Boston site must satisfy American ones. And the sponsor, hoping for simultaneous global approval, must ensure the trial satisfies everyone.

This lesson introduces the global regulatory landscape for clinical trials. You will learn how the International Council for Harmonisation works to align standards across regions, how major regulatory authorities approach clinical trial oversight, and why understanding regional differences matters for anyone working in international research.

This scenario is not unusual. It is, in fact, the norm for modern pharmaceutical development. And it raises an immediate practical question: whose rules apply?

The answer is both simple and complex. Simple, because a foundational principle holds across all major jurisdictions: protect research participants, ensure data reliability. Complex, because each regulatory authority has its own laws, its own procedures, its own interpretations. A clinical trial conducted in Tokyo must satisfy Japanese requirements. The same trial's Boston site must satisfy American ones. And the sponsor, hoping for simultaneous global approval, must ensure the trial satisfies everyone.

This lesson introduces the global regulatory landscape for clinical trials. You will learn how the International Council for Harmonisation works to align standards across regions, how major regulatory authorities approach clinical trial oversight, and why understanding regional differences matters for anyone working in international research.